SCHEMBL21749370

SCHEMBL21749370

COc1ccc(Cn2nc(Cc3c(Cl)cc(OC(=O)NCc4noc(=O)[nH]4)cc3Cl)cc(C(C)C)c2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 8/20 0.42
▸ THRB P10828 8/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NPBWR1 P48145 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RAB9A P51151 2/20 0.34
▸ PTGES O14684 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21749484 0.87 THRB (0.53) THRATHRB
SCHEMBL21749369 0.82 THRA (0.38) THRATHRBSMN1; SMN2MEN1KMT2A
SCHEMBL21749489 0.80 THRB (0.52) THRATHRB
SCHEMBL28566985 0.80 NPBWR1 (0.43) THRATHRBNPBWR1
SCHEMBL31664927 0.79 THRA (0.36) THRATHRBSMN1; SMN2MEN1KMT2A
SCHEMBL21769495 0.75 THRB (0.36) THRATHRBSMN1; SMN2MEN1KMT2A
SCHEMBL21749380 0.75 NPBWR1 (0.47) THRATHRBNPBWR1NPSR1
SCHEMBL21749361 0.74 THRB (0.73) THRATHRB
SCHEMBL21749367 0.74 THRB (0.74) THRATHRB
SCHEMBL28566363 0.74 PTGDR2 (0.42) THRBSMN1; SMN2MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3840755-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2021-06-30 — — EP disclosed
US-10800767-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2020-10-13 — — US disclosed
WO-2020041741-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2020-02-27 — — WO disclosed
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRA 2/4885THRB 1/4885SMN1; SMN2 4704/4885
US-10800767-B2 Thyroid hormone receptor beta agonist compounds THRB, THRA, TSHR THRA 2/4885THRB 1/4885SMN1; SMN2 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback